Winton Group LTD Global Blood Therapeutics, Inc. Transaction History

Winton Group LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$32.4 - $68.18 $92,955 - $195,608	-2,869 Reduced 12.26%	20,528 $1.4 Million
Q2 2022 Aug 10, 2022	BUY	$22.3 - $37.39 $85,007 - $142,530	3,812 Added 19.46%	23,397 $748,000
Q1 2022 May 11, 2022	SELL	$25.68 - $35.59 $118,076 - $163,642	-4,598 Reduced 19.01%	19,585 $678,000
Q4 2021 Feb 10, 2022	BUY	$24.9 - $40.26 $360,004 - $582,079	14,458 Added 148.67%	24,183 $708,000
Q3 2021 Oct 28, 2021	SELL	$25.48 - $37.34 $216,885 - $317,838	-8,512 Reduced 46.67%	9,725 $248,000
Q2 2021 Aug 10, 2021	BUY	$32.46 - $43.42 $79,007 - $105,684	2,434 Added 15.4%	18,237 $639,000
Q1 2021 Jul 21, 2021	BUY	$38.94 - $50.85 $615,368 - $803,582	15,803 New	15,803 $644,000
Q4 2020 Feb 12, 2021	SELL	$37.65 - $63.77 $705,937 - $1.2 Million	-18,750 Closed	0 $0
Q3 2020 Oct 30, 2020	BUY	$52.76 - $74.49 $989,250 - $1.4 Million	18,750 New	18,750 $1.03 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.